Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Accumulating evidence suggests that the gut microbiota is an important factor in mediating the development of obesity-related metabolic disorders, including type 2 diabetes. Metformin and berberine, two clinically effective drugs for treating diabetes, have recently been shown to exert their actions...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Zhao, Yufeng, Xu, Jia, Xue, Zhengsheng, Zhang, Menghui, Pang, Xiaoyan, Zhang, Xiaojun, Zhao, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585776/
https://www.ncbi.nlm.nih.gov/pubmed/26396057
http://dx.doi.org/10.1038/srep14405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585776/
https://www.ncbi.nlm.nih.gov/pubmed/26396057
http://dx.doi.org/10.1038/srep14405

Ejemplares similares